Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Sep;48(3):417–421. doi: 10.1038/bjc.1983.207

Effect of clofibrate on the growth-kinetics of the murine P 1798(sc) lymphoma.

F M Ubeira, R Seoane, E Puentes, J Faro, B J Regueiro
PMCID: PMC2011464  PMID: 6351886

Abstract

Clofibrate (CPIB) is a drug applied as an antilipidaemic agent in mammals. In this work we have tested its efficacy in vivo on the growth kinetics of P 1798(sc) lymphoma transplanted to recipient (BALB/c x AKR)F1 mice. Our results show a facilitation of the tumour growth rate in treated recipients. This fact may be related to an effect of the agent on the recipient which produces a decrease in the immune response as was confirmed on testing CPIB on thymus-dependent antigens in haemolytic plaque assays.

Full text

PDF
417

Images in this article

419Figure 3
on p.419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATTIA M. A., DEOME K. B., WEISS D. W. IMMUNOLOGY OF SPONTANEOUS MAMMARY CARCINOMAS IN MICE. II. RESISTANCE TO A RAPIDLY AND A SLOWLY DEVELOPING TUMOR. Cancer Res. 1965 May;25:451–457. [PubMed] [Google Scholar]
  2. AVOY D. R., SWYRYD E. A., GOULD R. G. EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER. J Lipid Res. 1965 Jul;6:369–376. [PubMed] [Google Scholar]
  3. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  4. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973 May;19(5):476–482. [PubMed] [Google Scholar]
  5. Cederblad G., Korsan-Bengtsen K. Effect of clofibrate on plasma proteins including components of the hemostatic mechanism. Clin Chim Acta. 1976 Jan 2;66(1):9–17. doi: 10.1016/0009-8981(76)90366-1. [DOI] [PubMed] [Google Scholar]
  6. Cohen A. J., Grasso P. Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol. 1981 Oct;19(5):585–605. doi: 10.1016/0015-6264(81)90509-5. [DOI] [PubMed] [Google Scholar]
  7. Cunningham A. J., Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 1968 Apr;14(4):599–600. [PMC free article] [PubMed] [Google Scholar]
  8. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  9. Hoover R., Fraumeni J. F., Jr Drug-induced cancer. Cancer. 1981 Mar 1;47(5 Suppl):1071–1080. doi: 10.1002/1097-0142(19810301)47:5+<1071::aid-cncr2820471304>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  10. LAMPKIN J. M., POTTER M. Response to cortisone and development of cortisone resistance in a cortisone-sensitive lymphosarcoma of the mouse. J Natl Cancer Inst. 1958 Jun;20(6):1091–1111. doi: 10.1093/jnci/20.6.1091. [DOI] [PubMed] [Google Scholar]
  11. Quan Z. S., Dick R. F., Regueiro B., Quintáns J. B cell heterogeneity. II. Transplantation resistance in xid mice which affects the ontogeny of B cell subpopulations. Eur J Immunol. 1981 Aug;11(8):643–649. doi: 10.1002/eji.1830110810. [DOI] [PubMed] [Google Scholar]
  12. Reddy J. K., Krishnakantha T. P. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science. 1975 Nov 21;190(4216):787–789. doi: 10.1126/science.1198095. [DOI] [PubMed] [Google Scholar]
  13. Reddy J. K., Qureshi S. A. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer. 1979 Sep;40(3):476–482. doi: 10.1038/bjc.1979.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schlager S. I., Ohanian S. H., Borsos T. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid. J Immunol. 1978 Feb;120(2):463–471. [PubMed] [Google Scholar]
  15. Schlager S. I., Ohanian S. H. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack. Science. 1977 Aug 19;197(4305):773–776. doi: 10.1126/science.196331. [DOI] [PubMed] [Google Scholar]
  16. THORP J. M., WARING W. S. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature. 1962 Jun 9;194:948–949. doi: 10.1038/194948a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES